|
 |
Drug Houses of Australia (Asia) Pte. Ltd.
|
|
Drug Houses of Australia (Asia) Pte. Ltd. (DHA), a wholly-owned subsidiary of Haw Par Healthcare, is a leading name among Singapore's manufacturers of pharmaceutical products.
Haw Par Healthcare is the pharmaceutical division of Haw Par Corporation Limited. Haw Par Corporation Limited's core business is in the areas of healthcare and leisure. The company also has interests in investment properties and manages its own portfolio of long-term and short-term investments in securities.
Established in 1969, DHA has since emerged as a leading generic manufacturer in Singapore. Through the years, DHA has maintained a simple but focused corporate philosophy to provide reliable and quality pharmaceutical products through stringent quality control.
DHA has the Singapore Ministry of Healths certification as a manufacturer meeting the Pharmaceutical Inspection Co-operation Scheme (PICS) Guide to Good Manufacturing Practice (GMP) for medicinal products, which encompasses all recommendations of the World Health Organisation (WHO) in relation to GMP.
|
|
 |
|
 Selling Category
Chemical, Rubber and Plastic Products
- Pharmaceutical Chemicals |
Laboratory and Pharmaceutical Instruments
- Biotechnology Products |
Laboratory and Pharmaceutical Instruments
- Injection Needles |
Laboratory and Pharmaceutical Instruments
- Medical Products - Manufacturers |
Laboratory and Pharmaceutical Instruments
- Pharmaceutical Products |
|
|
|
|
|
|
|
| Company Name |
Drug Houses of Australia (Asia) Pte. Ltd. |
| Address |
No. 2, Chia Ping Road, #09-00, Haw Par Tiger Balm Building, Singapore , 619968 Others, Others, Singapore |
| Phone |
65-6265-2777 |
| Fax |
65-6261-5887 |
| Homepage |
-
|
| Contact |
Gor Bee Leong |
|
|
|
|
|
|
|
|
|